ArticleEuropean heart journal2021
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19.
Massimo Volpe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it